Pharma Deals Review, Vol 2007, No 86 (2007)

Font Size:  Small  Medium  Large

Merck & Co. Signs Major Drug Delivery Deal with SurModics

Business Review Editor

Abstract


Merck & Co. has committed up to US$308 M to license and research collaboration agreement with SurModics. The alliance with SurModics aims to pursue the joint development and commercialization of SurModics’ I-vation™ sustained drug delivery system in combination with triamcinolone acetonide.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.